comparemela.com
Latest Breaking News On - Jan gosepath - Page 1 : comparemela.com
Intersect ENT, Inc.: Intersect ENT Receives CE Mark Approval for PROPEL Contour for Patients with Chronic Rhinosinusitis Following Frontal Sinus Surgery
Localized steroid-releasing sinus implant designed to maintain sinus opening now available in select EU countries Intersect ENT, Inc. (Nasdaq: XENT), a global ear, nose and throat ("ENT") medical
United-kingdom
Wiesbaden
Hessen
Germany
Randy-meier
Erich-sandoval
Jan-gosepath
Exchange-commission
Intersect-ent-inc
Department-of-otolaryngology
European-union
Securities-exchange
vimarsana © 2020. All Rights Reserved.